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A B S T R A C T
CXXC domains have traditionally been considered as CpG speciﬁc DNA binding domains that are repelled by
cytosine modiﬁcations. This view has recently been challenged by the demonstration that CXXC domain of TET3
has relaxed sequence speciﬁcity and binds with the highest aﬃnity to symmetric DNA duplex containing
5caCpG. Here, we present a comparative analysis of the MLL1-CXXC and TET3-CXXC sequence speciﬁcity and
tolerance to cytosine modiﬁcations (5-methyl, 5-hydroxymethyl, 5-formyl, 5-carboxyl) in CpG and non-CpG
context. For the ﬁrst time, we take into consideration possible interference from cytosine bases elsewhere in the
sequence. We show that despite similar overall structure, MLL1-CXXC has greater sequence and modiﬁcation
speciﬁcity than TET3-CXXC. MLL1-CXXC is speciﬁc only for CpG and does not tolerate any cytosine modiﬁca-
tions. In contrast, TET3-CXXC does not require the CpG context of cytosine bases. Methyl-, formyl- and carboxyl-
modiﬁcations are tolerated by TET3-CXXC, but only preceding G. Based on our and other data we propose a
parsimonious model of MLL1-CXXC and TET3-CXXC DNA binding. This model explains why the binding of
modiﬁed DNA duplexes by TET3-CXXC requires in some cases a register shift and is therefore context-dependent.
1. Introduction
Cytosine methylation in vertebrates is mostly limited to the CpG
context, in which up to 80% of cytosines are modiﬁed [1,2]. CpG-rich
regions (termed the CpG islands, CGIs) are frequently associated with
gene promoters that are methylated to varying extent in diﬀerent cell
types, causing transcriptional repression [3,4]. As all other en-
zymatically generated cytosine modiﬁcations in eukaryotic DNA are
derived from 5-methylcytosine (5mC) [5–7], the CpG context is typical
not only for 5mC, but also its oxidized derivatives: 5-hydro-
xymethylcytosine (5hmC), 5-formylcytosine (5fC) and 5-carbox-
ylcytosine (5caC). In contrast to 5mC, its oxidized derivatives are as-
sociated rather with activation than repression of transcription [7,8].
CXXC domains are small DNA binding domains (~50 amino acids)
that are built around two structural Zn2+ ions, which are chelated by
eight cysteine residues. Most studies of CXXC domain containing pro-
teins have suggested that CXXC domains are CpG dinucleotide speciﬁc
and are repelled by methylation of at least one cytosine within CpG
[9–13]. Recently, protein binding microarray (PBM) experiments have
shown that the sequence speciﬁcity of CXXC domains is not as uniform
as previously thought [14]. Based on the sequence logos of speciﬁcally
bound DNA, CXXC domains were grouped into four diﬀerent classes (I-
IV) [14], which roughly correlate with phylogenetic groups [12]. Class I
CXXC domains are represented by CFP1 that binds to DNA containing
CpGpG trinucleotides [14]. Class II CXXC domains (present in MLL1
and MLL2, among others) are shown to be strictly CpG-speciﬁc, re-
quiring no other DNA bases outside the CpG sequence [14]. Class III
CXXC domains are present e.g. in the TET1 and TET3 proteins. Ac-
cording to the sequence logo, the sequence speciﬁcity of this subgroup
is low, and there is at most a slight preference for CpG over CpA, CpT
and CpC [14]. Finally, the class IV proteins (represented by the CXXC
domains of DNMT1, among others) bind DNA weakly or not at all [14].
We decided to focus on the representative CXXC domains from group II
and group III, MLL1 and TET3.
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The MLL1-4 (also called KMT2A-KMT2D) proteins have been named
for the involvement of the ﬁrst identiﬁed family member (MLL1) in
mixed lineage leukemia (MLL) [15]. The MLL1-4 proteins are the cat-
alytic cores of large multiprotein COMPASS complexes, which mediate
positive genetic memory [16]. MLL1 (KMT2A) and MLL2 (KMT2B)
catalyze H3K4 trimethylation (H3K4me3) at promoters, MLL3 (KMT2C)
and MLL4 (KMT2D) proteins mediate H3K4 monomethylation
(H3K4me1) at enhancers [17]. As CpG islands are typical for promoters,
only promoter-speciﬁc MLL1 and MLL2 (but not MLL3 and MLL4)
possess CpG-speciﬁc CXXC domains. Based on their biochemical prop-
erties, the MLL1 and MLL2 CXXC domains are thought to implement a
positive feed-forward loop between activating histone marks and the
absence of repressive DNA methylation marks at promoters [10].
Ten-eleven translocation (TET) proteins have been named for
chromosomal rearrangements aﬀecting the founding member of the
family, TET1, one of three TET orthologues [18–20]. The TET proteins
are α-ketoglutarate dependent dioxygenases that oxidize 5mC to 5hmC,
5fC, and ﬁnally 5caC [5,7]. The higher oxidation products of TET-
mediated 5mC oxidation (5fC and 5caC) bear many hallmarks of DNA
damage [21]. They are excised and replaced by base excision repair
(BER), and possibly other DNA repair pathways [7,22]. In stark contrast
to the widely held belief that CXXC domains require non-modiﬁed cy-
tosine bases for binding, the TET3 CXXC domain has been reported to
bind also 5mCpG in some sequence contexts [23]. Moreover, the TET3
CXXC domain has also been found to bind at least as well to 5caCpG
(present on both strands) as to CpG [24].
Structures of CXXC domains have been extensively characterized
using crystallography and NMR approaches. In particular, structures of
the CXXC domain of human MLL1 in complex with non-methylated CpG
containing DNA have been determined in solution using NMR (PDB ID:
2KKF) [10], and recently, also by X-ray crystallography (PDB ID:
4NW3) [14]. Even more structural information is available for the TET3
CXXC domain. Human and Xenopus tropicalis domains have been crys-
tallized with non-modiﬁed CpG DNA (PDB IDs: 4Z3C, 4HP3) [14,23],
and the Xenopus tropicalis domain has also been crystallized with me-
thylated CpG (5mCpG) side on both DNA strands (PDB ID: 4HP1) [23].
In addition, there is a structure of the murine Tet3 CXXC domain
crystallized in complex with 5-carboxylcytosine (5caC) replacing the
cytosine of the CpG also on both DNA strands (PDB ID: 5EXH) [24].
The modiﬁcation speciﬁcities of MLL1 and TET3 CXXC domains are
partially known already. For the MLL1 CXXC domain, speciﬁcity has
been determined with regard to DNA methylation [9,10], but the eﬀect
of other DNA modiﬁcations has not yet been investigated. In contrast,
the modiﬁcation speciﬁcity of the TET3 CXXC domain has been the
subject of several studies [14,23,24]. Despite the demonstration by Xu
and colleagues in 2012 that the TET3 CXXC domain requires only cy-
tosine, but not the CpG context [23], almost all analyzed oligonucleo-
tides contained several C bases. Moreover, most structural and bio-
chemical data were collected using DNA duplexes that had
symmetrically placed 5mC, 5hmC, 5fC and 5caC bases. Such arrange-
ments of modiﬁed bases simplify interpretation of binding data, but are
physiologically atypical.
Here, we report a comparison of the speciﬁcities of the human MLL1
and TET3 CXXC domains (MLL1-CXXC and TET3-CXXC) bound to
dsDNA containing either cytosine, 5mC, or an enzymatically oxidized
5mC derivatives (5hmC, 5fC, 5caC), in CpG or non-CpG context. With
respect to CXXC domain speciﬁcity towards non-modiﬁed DNA, our
work extends a recent detailed analysis [14], but accounts more care-
fully for possible confounding inﬂuences of cytosine bases away from
the site of interest. With respect to CXXC domain preferences for
modiﬁed versus non-modiﬁed DNA bases, we focus on the physiologi-
cally relevant combinations of modiﬁcations in the two DNA strands
(modiﬁed bases in dyads either with non-modiﬁed C or 5mC), rather
than on the most straightforwardly analyzable, symmetric cases (such
as 5caCpG/5caCpG dyads). We also pay much greater attention than
previous authors to the inﬂuence of solubility and ﬂuorescence
anisotropy enhancing tags, which – when consistently used – do not
alter the outcome of direct comparisons, but can signiﬁcantly aﬀect
quantitative conclusions, especially regarding dissociation constants.
Based on our observations and the available crystal structures, we
propose a model that summarizes observed MLL1-CXXC and TET3-
CXXC domain sequence preferences and modiﬁcation speciﬁcities. The
model sheds light on CXXC molecular recognition of the DNA bases,
explains why MLL1-CXXC recognizes only CpG in context independent
way and justiﬁes the register shifts observed in some TET3-CXXC/
dsDNA co-crystal structures.
2. Results
2.1. CXXC domain constructs used in this work
CXXC domains were expressed in bacterial system as fusion proteins
with various solubility enhancing tags (HisSUMO, SUMO, GST), and
optionally cleaved from these tags. The aﬃnity of these proteins to
tested DNA oligonucleotides was then assessed using both electro-
phoretic mobility shift assays (EMSA) and ﬂuorescence anisotropy ex-
periments. During the course of this study, it became clear that the tags
contributed clearly to keeping the CXXC domains soluble and functional
(for DNA binding). By themselves, the tags exhibited at most marginal
DNA binding (Fig. S1A). However, when the tags were fused to the
CXXC domains, they had a signiﬁcant and consistent eﬀect not only on
maximal ﬂuorescence, but also on dissociation constants, both ac-
cording to ﬂuorescence anisotropy experiments (Fig. S1B) and the
electrophoretic mobility shift assay (EMSA) (Fig. S1C). As perhaps ex-
pected, based on the positive charge of the His-tag, the HisSUMO tag
enhanced aﬃnity to DNA most strongly. Despite the more than twice
smaller size compared to GST (≈11 kDa compared to≈26 kDa), it also
led to the highest observed ﬂuorescence anisotropy (Fig. S1B). In EMSA
gels, GST-MLL1-CXXC exhibited a preference for modiﬁed CCGT that
was not seen with the non-tagged protein (Fig. S1D). Apart from GST-
MLL1, comparisons between diﬀerent CXXC domains for the same DNA,
or one CXXC domain for diﬀerent DNAs, yielded consistent results for
diﬀerent tags, so that qualitative conclusions were not aﬀected (Fig.
S2). In the following, we therefore show only representative results for
the protein fused with HisSUMO-tag.
2.2. MLL1-CXXC is more CpG speciﬁc than TET3-CXXC
At the outset of our studies, we compared the sequence speciﬁcity of
MLL1-CXXC and TET3-CXXC using 30-mer dsDNA that contained
modiﬁed or non-modiﬁed cytosines in a central CpG dyad or other se-
quence context and several other cytosine bases elsewhere in the duplex
(Table S1, 30mers). In the experiments with MLL1-CXXC, we observed a
speciﬁc shift exclusively in the presence of non-modiﬁed CpG. In other
lanes, only an unspeciﬁc smear was seen (observed above the speciﬁc
band) (Fig. 1A). In contrast, multiple retarded bands were seen in the
otherwise same experiment using the TET3-CXXC (note especially for
non-CpG duplexes). Judging from band intensity and the degree of re-
tardation, TET3-CXXC bound best to non-modiﬁed CpG duplexes
(Fig. 1B, ﬁrst lane). Otherwise, similar patterns of retardation were
observed for all cytosine modiﬁcations (Fig. 1B).
To monitor retarded bands, we performed EMSA experiments with
increasing concentration of MLL1-CXXC and TET3-CXXC with constant
concentration of non-modiﬁed DNA duplexes (containing or lacking
CpG dinucleotides) (Fig. 1C–F). We conﬁrmed that MLL1-CXXC created
only single speciﬁc band with CpG-containing duplex, even at high
protein concentrations (Fig. 1C). In case of non-CpG DNA we detected
only an unspeciﬁc smear (Fig. 1E). In contrast, TET3-CXXC generated
several super-shifts, suggesting binding at multiple sites. Retarded
bands appeared at lower protein concentration for CpG containing
compared to non-CpG containing oligonucleotides, but eventually
shifted bands were seen for all sequence contexts at high protein
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concentration (Fig. 1D and F). These results are consistent with litera-
ture data and conﬁrm binding of TET3-CXXC to any cytosine, with
moderate preference for the CpG context [23].
Fluorescence anisotropy experiments conﬁrmed the preference for
binding of MLL1-CXXC and TET3-CXXC to CpG over non-CpG con-
taining DNA duplexes (Fig. S2A, S2D). They were also consistent with
the EMSA result that the TET3-CXXC preference for CpG over non-CpG
was very mild. Somewhat surprisingly the pronounced preference of
MLL1-CXXC for CpG over non-CpG seen in the EMSA experiments was
only clearly apparent in the ﬂuorescence anisotropy experiments when
the GST-tagged version of the protein fragment was used, whereas the
diﬀerence appeared milder for the constructs with the HisSUMO and
SUMO tags (Fig. S2A).
2.3. Design of improved, short (12mer) oligonucleotides without cytosine
bases outside the site of interest
To avoid the confounding inﬂuence of C:G base pairs outside the
CpG context in the case of TET3-CXXC (Fig. 1B, D, F), we designed a set
of shorter (12mer) DNA duplexes that have only A:T base pairs in the
ﬂanking sequence (Table S1, 12mers). As a control we also included one
non-CpG 12mer with multiple C:G base pairs (Table S1, ACAT (GC)).
In addition to DNA duplexes containing non-modiﬁed C in the
complementary strand, we aimed to test the physiologically more re-
levant situation with 5mC rather than C in the complementary strand
(possible only for CpG containing duplexes). Other modiﬁcations than
5mC were not investigated in the complementary strand, because
combinations of 5hmC, 5fC and 5caC bases in the two DNA strands are
unlikely in vivo, due to the scarcity of these bases [25]. Moreover,
combinations of 5fC and 5caC are likely to be avoided in vivo because
they create a double strand break hazard [7,26,27].
The set of oligonucleotides contained not only diﬀerent modiﬁca-
tions but also three sequence-contexts (CCGT, ACGT and TCGA; Table
S1). These were chosen to minimize the number of C:G base pairs
outside the CpG context. As a result of this design, the sequences dif-
fered from the CCGG sequence that is most frequently present in the
TET3-CXXC and dsDNA co-crystal structures.
2.4. MLL1-CXXC binds only non-modiﬁed CpG
As in the experiments with 30mers (Fig. 1A), the EMSA experiment
of MLL1-CXXC with 12mer oligonucleotides showed high speciﬁcity for
DNA duplexes containing exclusively non-modiﬁed CpG (Fig. 2A, B).
Any single CpG modiﬁcation abolishes interaction between DNA and
MLL1-CXXC. We also observed, that neither the bases upstream nor
downstream of the CpG signiﬁcantly inﬂuenced binding of MLL1-CXXC
for the three tested sequence contexts (Figs. S2B, S3A). Moreover,
MLL1-CXXC did not bind to any of CpA-containing oligonucleotides,
even in the presence of additional C:G base pairs (Fig. 2A, compare C
and C(GC) lanes of ACAT duplex). Binding experiments with short
oligoduplexes did not exhibit the smear that was seen in the EMSA gels
with 30mers. Perhaps it reﬂects lesser opportunities to bind to the short
arms of the duplex ﬂanking the site of interest. Fluorescence anisotropy
experiments conﬁrmed that MLL1-CXXC bound DNA containing an
unmodiﬁed CpG dyad much better than DNA containing a modiﬁed
dyad (Fig. S2C).
Fig. 1. Binding of MLL1-CXXC and TET3-CXXC to 30mer oligonucleotide (containing multiple C:G base pairs beside central non-modiﬁed or hemi-modiﬁed C in CpG
or non-CpG context). EMSA experiments with A) MLL1-CXXC and B) TET3-CXXC with constant protein (2 μM) and dsDNA (100 nM) concentrations. C–F) EMSA
experiments with increasing concentration of MLL1-CXXC (C, E) or TET3-CXX (D, F) and 100 nM non-modiﬁed dsDNA.
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2.5. TET3-CXXC has weaker speciﬁcity towards non-modiﬁed CpG than
MLL1-CXXC
Like the MLL1-CXXC, the TET3-CXXC was bound to 12mer con-
sistently when a non-modiﬁed CpG was present (Fig. 2C). According to
the EMSA experiments, TET3-CXXC showed some preference for the
sequence context outside the CpG dinucleotide (CCGT~ACGT>TCGA)
(Fig. S3B), but this preference was not very clear from ﬂuorescence
anisotropy experiments (Fig. S2E). In the absence of additional cytosine
bases, the non-CpG preference of TET3 was absent (compare ACAT and
ACAT (GC) lanes) (Fig. 2C). Apparently, the TET3-CXXC requires
multiple C:G base pairs to bind DNA lacking CpG. This observation
stays in agreement with the binding of TET3-CXXC to 30mer containing
several cytosine residues (Fig. 1B).
According to the EMSA experiments, TET3-CXXC bound duplexes
that contained a modiﬁed C (only within CpG) also in a context-de-
pendent manner (Fig. 2C). The binding occurred predominantly when
the modiﬁed C of the CpG was 5mC and 5caC. Binding was tighter when
the modiﬁed bases was preceded by another C (CCGT), weaker when
preceded by an A (ACGT), and barely detectable for a T base (TCGA).
Fluorescence anisotropy analysis conﬁrmed binding with all modiﬁed
CpG (5mC, 5hmC, 5fC, 5caC) in CCGT context (Fig. S2F). When the
complementary strand contained 5mCpG instead of non-modiﬁed CpG,
using EMSA we observed binding to non-modiﬁed top strand in all three
sequence context as well as 5caCpG but only in CCGT context (Fig. 2D).
In the EMSA experiments with the 12mers and TET3-CXXC we
Fig. 2. Binding of MLL1-CXXC (A–B) and TET3-CXXC (C–D) to 12mer oligonucleotides lacking additional C:G base pair in the ﬂanking sequence. EMSA of MLL1-
CXXC with A) non-modiﬁed, hemi-modiﬁed or B) double-modiﬁed 12-mer DNA duplexes. Three diﬀerent CpG sequence contexts (CCGT, ACGT, TCGA) and one non-
CpG (ACAT) were analyzed. 12mer oligonucleotide with ACAT in the central position and additional C:G pairs was used as control with context similar to the 30mers.
Similarly, EMSA of TET3-CXXC with C) non-modiﬁed and hemi-modiﬁed or D) double-modiﬁed 12-mer DNA duplexes.
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observed two shifted bands (Fig. 2C). The upper band corresponded in
mobility to the DNA complex of MLL1-CXXC, which has a similar mass
and isoelectric point and is therefore expected to be similar. At higher
protein concentration, a second, lower band gradually predominated
(Fig. S3B). As this band represents a smaller or more charged species, it
could not be interpreted as a conventional super-shift. The reasons for
the appearance of the lower band are not clear. The occurrence of the
lower band is also present with palindromic oligoduplexes (Fig. S3C)
what excludes two equivalent binding modes as the cause of the shift.
Moreover, we could also rule out single strand DNA binding as a pos-
sible cause (Fig. S3D). The lower and higher shifted bands pre-
dominated for TCGA (Fig. 2C) and 5caCpG/5mCpG in CCGT context
(Fig. 2D), respectively. The reasons for this eﬀect remain unclear.
Fig. 3. Design of MLL1-like TET3-CXXC and TET3-like MLL1-CXXC chimeras by single point mutations and their binding properties. A) Protein sequence alignment
of CXXC domains created using ClustalW [28,29], as in [14]. Cys residues involved in Zn2+ binding are bolded. Red labels identify sites of point-mutations. B) Crystal
structures of wild-type: MLL1 (PDB ID: 4NW3) and TET3 (PDB ID: 4Z3C) [14]. EMSA results of 12mer DNA binding with C) MLL1-CXXC K1186H and D) TET3-CXXC
H81K variants. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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2.6. Design of MLL1-like TET3-CXXC and TET3-like MLL1-CXXC chimeras
According to the sequence alignment (Fig. 3A), D1175/K1186 in
MLL1-CXXC and N77/H81 in TET3-CXXC, among other amino acids,
are strongly conserved within each CXXC class, but not between classes.
D1175 in MLL1-CXXC (PDB ID: 4NW3) appears to be involved in rigi-
difying the structure in the DNA binding region (Fig. 3B) [9,10]. The
“equivalent” residue N77 in TET3-CXXC (PDB ID: 4Z3C) has at most a
minor structural role, but donates a hydrogen bond to the phospho-
diester backbone of DNA [14]. K1186 in MLL1-CXXC and H81 in TET3-
CXXC interact directly with the CpG target and could aﬀect speciﬁcity.
Prior tests of the D1175A and K1186A MLL1-CXXC variants have al-
ready shown that these residues are important for DNA binding, at least
in MLL1 [9]. We wondered whether we could exchange the MLL1-CXXC
and TET3-CXXC binding properties by single amino acid substitutions
(MLL1-CXXC D1175, K1186 and TET3-CXXC N77, H81) (Fig. 3A, B).
2.7. Binding properties of MLL1-CXXC and TET3-CXXC chimeras
Surprisingly, we observed that both MLL1-CXXC D1175N (Fig. S4A)
and TET3-CXXC N77D (Fig. S4B) variants lost aﬃnity to DNA alto-
gether. MLL1-CXXC K1186H variant was similar to the wild-type in its
requirement for CpG context and repellence by cytosine modiﬁcations,
but acquired a TET3-CXXC-like preference for ﬂanking sequence
(Fig. 3C). In contrast, the TET3-CXXC H81K variant changed speciﬁcity
more drastically. The variant could still bind to non-modiﬁed and
5mCpG containing 12mer oligonucleotide but it lost almost completely
the aﬃnity towards other modiﬁcations (Fig. 3D). As the wild-type
TET3-CXXC, the TET3-CXXC H81K variant still disfavored the TCGA
context. In contrast to previous EMSA results for the wild-type TET3-
CXXC (Fig. 2D, F), only a single shift predominated for non-modiﬁed
CpG bound by TET3-CXXC H81K variant (Fig. 3D).
3. Discussion
3.1. A simple model of CXXC domains binding speciﬁcity
We analyzed available crystal structures of MLL1-CXXC (PDB ID:
4NM3) and TET3-CXXC (PDB ID: 4HP1, 4HP3, 4Z3C, 5EXH) together
with the results obtained in this study. Based on this data we created a
model for CXXC binding speciﬁcity that explains the available crystal-
lographic data and is consistent with biochemical data reported in this
work.
The CXXC domain model features PC:PG and PG*:PC* sites for ad-
jacent C:G and G:C base pairs, respectively (where P stands for pocket)
(Fig. 4A). The canonical binding mode places the CpG dinucleotides of
the two DNA strands in the PC-PG* and PC*-PG sites (listed in 5′-3′-
direction for the respective strands). For CXXC domains of relaxed se-
quence speciﬁcity, a register shift binding mode can occur, when the
canonical binding mode is precluded by DNA modiﬁcations. MLL1-
CXXC and TET3-CXXC diﬀer in the selectivity of pockets and the pro-
pensity for register shifts. MLL1-CXXC is highly sequence selective and
does not tolerate modiﬁcations. TET3-CXXC has more relaxed speciﬁ-
city. It may also accommodate 5mC:G pair in PC:PG, and a 5fC:G or
5ca:G pair in PG*:PC*. Placement of 5fC or 5caC in PG*, normally a
guanine binding site, is facilitated by the formation of a favorable hy-
drogen bond or salt bridge to the 5-formyl or 5-carboxyl group, re-
spectively.
3.2. Register shifts help to interpret crystallographic and biochemical data
The binding model presented in this work correctly predicts the
register of binding of DNA in all MLL1-CXXC and TET3-CXXC crystal
structures. All structures of CXXC domains in complex with DNA con-
tain a CpG or modiﬁed CpG dinucleotide. The ones that contain a non-
modiﬁed CpG (PDB IDs: 2KKF, 4NW3, 4Z3C, 4HP3) bind it in the
expected register, with the C bases in PC and PC*, and the G bases in PG
and PG*.
In the structures of the xtTet3-CXXC with symmetric 5mCpG (PDB
ID: 4HP1) and mTet3-CXXC also with symmetric 5caCpG (PDB ID:
5EXH), the CpG dinucleotide is preceded by a C (CCGG sequence con-
text). In both cases register shifts occur that place the Cp5mC or Cp5caC
in the place normally taken by the CpG (Fig. 4A, top). In terms of the
model, the PC:PG site occupied by C:G (preceding CpG) and PG*:PC* by
5mC/5caC:G base pairs. Our model assumes that 5fC and 5caC can only
be accommodated when shifted. Single 5mC modiﬁcation likely can ﬁt
into canonical register (5mC in PC site), but when modiﬁcations are
present in both strands, a register shift is required (Fig. 4A, bottom).
5hmC bases cannot be accommodated either way, and therefore DNAs
containing this base (and no other binding site) are not bound. In some
cases, register shifted and non-shifted states may co-exist. Together
with a PC preference (C > A > T), this may explain at least in part the
context preference of TET3-CXXC (CCGT~ACGT > TCGA) seen in the
EMSA experiments.
3.3. PC:PG and PG*:PC* properties in structural terms
Available structural data readily explain the shared properties of
PC:PG and PG*:PC*, and the interactions with CpG containing DNA in
the canonical binding mode. A speciﬁcity tripeptide (SPT, residues
SPT1-3, 1185-KKQ-1187 in MLL1, 80-THQ-82 in TET3) contributes the
sequence selective hydrogen bonding interactions.
PC:PG has similar, albeit not identical properties in MLL1-CXXC and
TET3-CXXC, and is both sequence and modiﬁcation speciﬁc (Fig. 4B).
Sequence speciﬁcity appears to depend on hydrogen bonds in the major
groove (from the cytosine N4 to the main chain carbonyl of the SPT2
residue, and from the SP2 side chain, to the N7 atom of the guanine).
MLL1-CXXC PC:PG accepts well only a non-modiﬁed C:G base pair.
TET3-CXXC may also accept 5mC:G pair, but not as well as a non-
modiﬁed C:G pair. This diﬀerence may result from a slight shift of the
cytosine base towards the sidewall, or a more rigid pocket due to sta-
bilization by a neighboring helix [9], in MLL1-CXXC compared to TET3-
CXXC. Rejection of 5hmC, 5fC and 5caC from the PC of TET3-CXXC is
readily attributable to steric exclusion with the main chain ~5–6 Å
away from the C5 atom of a bound cytosine. Thus, only the accom-
modation of a methyl group is marginally possible.
PG*:PC* diﬀers between MLL1-CXXC and TET3-CXXC (Fig. 4C). In
MLL1-CXXC, this pocket is also sequence speciﬁc and does not tolerate
any other base than G in PG* site. In TET3-CXXC, the sequence speci-
ﬁcity is relaxed and PG*:PC* can accommodate other base pairs. When
a non-modiﬁed G:C pair is bound, the SPT3 glutamine donates a hy-
drogen bond to the guanine O6, the main chain carbonyl oxygen atom
of SPT1 (K1185 in MLL1, T80 in TET3) accepts a hydrogen bond from
the cytosine N4. When a register shift occurs, the SPT3 glutamine side
chain leaves its canonical position and reaches out to the cytosine N4 of
the complementary strand. This shift enlarges the PG* site and makes
space for base modiﬁcations. In contrast, the PC* in both MLL1 and
TET3 cannot accommodate any modiﬁcations. There is little space in
the vicinity of the C5 atom in the crystal structures, and rejection of
5mC, 5hmC, 5fC or 5caC in PC* is readily explained by severe steric
conﬂict (even addition of a methyl group leads to distances about 1.4 Å
below the sum of van der Waals radii).
3.4. Biological implications of our data, showing high speciﬁcity of MLL1-
CXXC for the non-modiﬁed CpG
At the outset of this project, we were aware of the high similarity
between CpG binding regions (SPT), and of the very similar spaces for
methyl groups in the MLL1-CXXC and TET3-CXXC complexes with
DNA. We therefore initially expected that MLL1 may be recruited to
sites of 5caC, as reported for TET3 [24]. Such recruitment would sug-
gest a role in transcriptional activation, and appeared to be odds with
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the accepted role of MLL1 in transcriptional memory, i.e. its action on
chromatin that is already transcriptionally active. This work shows that
MLL1-CXXC binds only to non-modiﬁed CpG. Therefore, there is no
paradox, and the biochemical properties of MLL1-CXXC are consistent
with the biological role of MLL1 in transcriptional memory.
Although our experiments have addressed only the properties of the
MLL1-CXXC, it is very likely that the properties are general to the entire
class II (as suggested also by Xu and colleagues [14]), and in particular
to MLL2, with the same physiologically plausible implications. In
addition to CXXC domain, we believe that for the precise recognition of
the MLL1 and MLL2 biological targets, PHD domains also play an im-
portant role [30].
3.5. Biological importance of our data conﬁrming TET3-CXXC binding to
the modiﬁed CpG
Studies of the murine Tet proteins (including Tet3) have shown that
the CXXC domains are not essential for Tet function [12]. Nevertheless,
Fig. 4. MLL1-CXXC and TET3-CXXC binding with non- and modiﬁed dsDNA. A) Schematic model of MLL1-CXXC and TET3-CXXC binding to non- and modiﬁed CpG-
containing dsDNA. Top – available crystal structures of MLL1 and TET3. Bottom – predicted registers. A single 5mC modiﬁcation can be accommodated in PC, unlike
larger modiﬁcations (5fC, 5caC) that require a shift of the binding register in 3′-direction of a top strand. Structures of B) PC:PG and C) PC*:PG* – MLL1 (PDB ID:
4NW3), TET3 (PDB ID: 4Z3C) and overlay of the two (top, middle, and bottom, respectively).
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it is likely that the CXXC domains are involved in protein targeting.
Recruitment of TETs to non-methylated CpG regions suggests that TETs
may be involved in the removal of “stray” methylation, introduced
erroneously in otherwise non-methylated regions. On the other hand,
recognizing the sites with 5caCpG and other modiﬁcations, suggests a
model whereby the TETs demethylate a region in a concerted manner
[24].
In this report, we conﬁrmed previous studies [14,23] that TET3-
CXXC binds also to DNA containing only multiple C:G base pairs. This
observation may imply that the CXXC domain serves not only as a
scanner for the CpG or modiﬁcation but also as an anchor for C-rich
sequences. Recruitment of TETs to 5caC sites, albeit limited to some
sequence contexts (C preceding 5caC), has been interpreted as a me-
chanism to locally demethylate DNA in the vicinity of a “priming” 5caC
base.
4. Materials and methods
4.1. Cloning, expression and puriﬁcation of wild-type and variant CXXC
domains
E. coli codon optimized synthetic genes (GeneArt, ThermoScientiﬁc)
encoding the CXXC domain of human MLL1 (UniProt: Q03164, aa
1147-1203) and of human TET3 (UniProt: O43151-4, aa 47-101) were
cloned into a pET28a-derived vector and pGEX-P6-2 to express the
fragments with N-terminal His-SUMO-tag and N-terminal GST-tag, re-
spectively. Variant constructs (MLL1-CXXC Asp1175Asn, Lys1186His as
well as TET3-CXXC Asn77Asp, His81Lys) were obtained by site-directed
mutagenesis on the wild type protein template of His-SUMO-tagged
CXXC domains. Empty pGEX-P6-2 was used for GST overexpression.
His-SUMO-CXXC and GST-CXXC proteins were overexpressed in E. coli
BL21(DE3)RIL cells under kanamycin and chloramphenicol selection
(50 μg/ml and 34 μg/ml, respectively), and in BL21(DE3) pLys cells
under ampicillin selection (100 μg/ml), respectively. Cells were grown
in LB medium to late logarithmic phase (OD600 of 0.5–0.8) at 37 °C,
cooled for half an hour, and then induced (0.4 mM IPTG) for overnight
protein expression at 24 °C. Cells were harvested the next day by cen-
trifugation, and pellets from 1 l culture batches were frozen and stored
for later use at -80 °C.
4.2. Protein puriﬁcation
4.2.1. His-SUMO-CXXC proteins
Producer cells from 1 l of culture were resuspended in 40ml ice-cold
Lysis Buﬀer (50mM Tris-HCl pH 7.5, 150mM NaCl) and supplemented
with PMSF and imidazole (ﬁnal concentration 1mM and 20mM, re-
spectively). After sonication, the lysate was cleared by ultra-
centrifugation. The supernatant was then applied on 5ml Ni-NTA beads
equilibrated with Lysis Buﬀer. After 1 h incubation, beads were ex-
tensively washed with High Salt Buﬀer (50mM Tris-HCl pH 7.5, 1M
NaCl), and then Washing Buﬀer (50mM Tris-HCl pH 7.5, 150mM NaCl,
20 mM imidazole). Elution was performed with 5ml Elution Buﬀer A
(50mM Tris-HCl pH 7.5, 150mM NaCl, 500mM imidazole), im-
mediately followed by 15ml Elution Buﬀer B (50mM Tris-HCl pH 7.5,
150mM NaCl, 300mM imidazole). To avoid precipitation, protein was
eluted to 20ml solution containing 50mM Tris-HCl, 300 μM ZnSO4,
2mM DTT. The eluate from the Ni-NTA column was then loaded on a
Heparin column. After washing with Lysis Buﬀer (50mM Tris-HCl
pH 7.5, 150mM NaCl, 150 μM ZnSO4 and 1mM DTT), protein was
eluted in NaCl gradient (up to 1M). The purity of eluate fractions was
assessed by SDS-gel electrophoresis. Fractions were then pooled, con-
centrated using Amicon Ultra (Millipore, 3 kDa cut-oﬀ) and dialyzed
overnight against storage buﬀer containing 50mM Tris-HCl pH 7.5,
150mM NaCl, 150 μM ZnSO4, 1mM DTT, 50% glycerol. The next day
protein concentration was measured, samples were aliquoted, frozen in
liquid nitrogen, and stored at −80 °C until further use. All the
puriﬁcation steps except the dialysis were done on the same day.
4.2.2. GST-MLL1-CXXC, GST protein
Producer cells from 1 l of culture were re-suspended in 40ml ice-
cold Lysis Buﬀer (50mM Tris-HCl pH 7.5, 400mM NaCl, 5% glycerol,
150 μM ZnSO4, 1mM DTT) and supplemented with 0.25mM PMSF.
After sonication, the lysate was cleared by 30min ultracentrifugation.
Next, the supernatant was applied on 5ml Glutathione Sepharose™ 4B
(GE Healthcare) beads, equilibrated with Lysis buﬀer. After 2 h in-
cubation, beads were extensively washed with Washing Buﬀer (50mM
Tris-HCl pH 8.0, 400mM KCl, 5% glycerol, 150 μM ZnSO4, 1mM DTT).
Protein was eluted by incubation of beads with 10ml Elution Buﬀer
(50mM Tris-HCl pH 8.0, 150mM KCl, 5% glycerol, 20mM L-glu-
tathione reduced, 150 μM ZnSO4, 1mM DTT) for overnight. The pur-
iﬁed protein was concentrated on Amicon Ultra ﬁlters (Amicon, 10 kDa
cut-oﬀ) and dialyzed overnight against storage buﬀer containing 1xPBS
supplemented with 150mM KCl, 150 μM ZnSO4, 1mM DTT, 10% gly-
cerol. The next day protein concentration was measured and samples
frozen until further use.
4.2.3. SUMO-CXXC, CXXC, HisSUMO and SUMO-tag proteins
His-SUMO tagged proteins were used to remove the His-tag by
thrombin or HisSUMO-tag by Ulp1 cleavage, performed overnight in
the cold room. Cleaved tags were removed by capture on Ni-NTA resin
(2 h, 4 °C). Ni-NTA resins with bound HisSUMO-tag were further used
for the incubation with Elution Buﬀer A (50mM Tris-HCl pH 7.5,
150mM NaCl, 500mM imidazole) to collect HisSUMO-tag. Next, the
portion of the puriﬁed HisSUMO-tag was incubated with thrombin and
incubated with Ni-NTA to collect puriﬁed SUMO-tag. MLL1-CXXC was
alternatively also obtained by on-column, PreScission-catalyzed clea-
vage of the protein, instead of the standard glutathione elution step.
The concentration of the CXXC domains without tag was assessed using
Pierce™ BCA Protein Assay Kit (ThermoScientiﬁc).
4.3. Electrophoretic mobility shift assay (EMSA)
100 nM FAM-labelled double-stranded DNA oligonucleotides (Table
S1) containing non- or modiﬁed central cytosine residue (5mC, 5hmC,
5fC, 5caC) were mixed either with MLL1-CXXC or TET3-CXXC (2 μM or
increasing concentration 0.1–6 μM) in ﬁnal 20 μl of reaction buﬀer
(10mM Tris-HCl, pH 7.5, 100mM KCl, 1 mM dithiothreitol, 150 μM
ZnSO4). Reaction mixtures were incubated on ice for 30min, after
which were supplemented with 4 μl of 6× native loading solution
(10mM Tris-HCl, pH 7.6, 60% glycerol, 0.03% bromophenol blue) and
immediately loaded on the 6% native PAGE. Electrophoresis was run in
cold room using ice-cold 0.5× TBE as a running buﬀer and constant
voltage (100 V) for 45min. Resolved FAM-labelled DNA was detected
using ﬂuorescence readout by Typhoon Trio+ (GE Healthcare).
4.4. Fluorescence anisotropy
The assay was performed in 96-well black, ﬂat-bottom polystyrene
NBS plates (Corning 3991) in 100 μl volume of reaction mixture each
well. 100 nM ﬂuorescently (FAM)-labelled double-stranded DNA (Table
S1) were mixed with increasing concentration (0.5, 1, 2, 5, 8, 10,
15 μM) of MLL1-CXXC or TET3-CXXC proteins in reaction buﬀer
(10mM Tris-HCl, pH 7.5, 100mM KCl, 1 mM dithiothreitol, 150 μM
ZnSO4). The mixtures were incubated at room temperature for 30min
and immediately afterwards the ﬂuorescence anisotropy was measured
by Tecan Inﬁnite M1000 ﬂuorescence microplate reader at 470 nm and
520 nm excitation and emission wavelength, respectively. The results
were normalized to the sample without protein and binding curves
were obtained using Prism software (GraphPad) with the one-site spe-
ciﬁc binding model with Hill slope.
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